SiRNA RSS

Filtered By:
Source: BMC Cancer
Cancer: Liposarcoma

Filter By:
Specialty
Source
Condition
Cancer
Infectious Disease
Drug
Training
Management
Procedure
Therapy
Vaccine
Nutrition
Country

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas
Conclusions: Our results suggest that AXL signaling contributes to the aggressiveness of DDLPS and PLS, and that AXL is therefore a potential therapeutic target for treatment of these rare, yet devastating tumors.
Source: BMC Cancer - November 14, 2015 Category: Cancer & Oncology Authors: Caitlin MayJeannine GarnettXiaoYan MaSharon LandersDavis IngramElizabeth DemiccoGhadah Al SannaaTona VuLixia HanYi ZhangChristine KivlinSvetlana BolshakovAzad KalamJuehui LiuFuguo ZhouDominique BroccoliWei-Lien WangAlexander LazarRaphael PollockDina LevKe Source Type: research